Clinical Trials on Schizophrenia Relapse
Total 0 results
Nothing found
Sponsors and Collaborators
- Health Parametrics Inc.
- Montreal Neurological Institute and Hospital
- The Third Hospital of Changsha
- New York State Health Foundation
- Northern California Melanoma Center
- John Granton
- Wushan County People's Hospital
- Kawin Technology Share-holding Co., Ltd.
- European Network For Smoking and Tobacco Prevention
- MingSight Pharmaceuticals Pty Limited
- Zahra Rabbani Khah
- Mitchell Scheiman
- Marilia Medicine School
- Jeffrey Rudolph
- Medtronic Atrial Fibrillation Solutions
- Ionis Pharmaceuticals
- Honda R and D Americas, Inc.
- CTC Bio, Inc.
- Jeffrey W. Clark, MD
- Rex Bionics Plc
- View Full List
Medical Conditions
- Nutritional Edema
- Heart Defect, Congenital
- Periodontology
- Develop a New Survey Instrument to Measure Behavioural Determinants of Hand Washing and Water Treatment Like Disgust and Shame or Social Pressure.
- Moderate to Severe Functional Impairments
- Fecal Elastase-1 Test
- Postmenopausal Diabetes
- Pertussis Immunisation
- Improved Vocal Fold Status
- Pediatric Anaplastic Large Cell Lymphoma
- Suspected Neonatal Encephalopathy
- Recurrent Primary Mediastinal (Thymic) Large B-Cell Lymphoma
- Idiopathic Gastric Stasis
- Myeloproliferative Disease
- Radial Artery Catheterization
- Acute Necrotizing Encephalopathy
- Canthal Lines
- Ketamine Treatment
- Influenza and Other Novel Respiratory Viruses
- Low Birthweight, Extremely (999 Grams or Less)
- View Full List
Drug Interventions
- Rifaximin
- CKD-519
- 5-Fluoro-3-Pyridinecarboxylic Acid
- ESK981
- Toripalimab plus Anlotinib
- Fludarabine
- Levcromakalim
- Up-and-down method to find out effective concentration of remifentanil for preventing cough during emergence
- Postoperative analgesia management
- Pentostatin
- Cyclophosphamide, Hydroxydaunorubicin, Oncovin, Prednisone/Prednisolone (CHOP)
- AZD7798
- Hydroxychloroquine
- 200 µg doxorubicin-containing MNA
- Tenofovir disoproxil fumarate (TDF) 300mg co-formulated with emtricitabine (FTC 200mg) once daily oral administration
- Irinotecan, capecitabine, oxaliplatin (IXO) and bevacizumab
- Bendamustine
- Nimotuzumab
- Ombrabulin (AVE8062)
- Levobupivacaine, clonidine
- View Full List
CROs by country
- Contract Research Organizations in Benin
- Contract Research Organizations in Burkina Faso
- Contract Research Organizations in Cameroon
- Contract Research Organizations in Congo
- Contract Research Organizations in Luxembourg
- Contract Research Organizations in Netherlands
- Contract Research Organizations in Oman
- Contract Research Organizations in Philippines
- Contract Research Organizations in Sri Lanka
- Contract Research Organizations in Thailand
- Contract Research Organizations in Togo
- Contract Research Organizations in Trinidad & Tobago
- Contract Research Organizations in United Arab Emirates
- CRO list by country